"Vhodn\u00E1 l\u00E9\u010Dba karcinomu \u0161t\u00EDtn\u00E9 \u017El\u00E1zy pomoc\u00ED 131 I destruuje n\u00E1dor a nikoliv tk\u00E1\u0148 zdravou. Kompromis je ur\u010Den osobn\u00ED biokinetikou, jej\u00ED\u017E kvalitn\u00ED odhad \u0159e\u0161itel\u00E9 navrhli. Projekt p\u0159iprav\u00ED klinicky pou\u017Eitelnou optimalizaci pod\u00E1v\u00E1n\u00ED 131 I. D\u00EDky tomu bude mo\u017En\u00E9 zkvalitnit l\u00E9\u010Dbu, radia\u010Dn\u00ED ochranu i provozn\u00ED ekonomiku. K tomu se objektivn\u011B vyhodnot\u00ED vliv individu\u00E1ln\u00ED biokinetiky a podan\u00E9 terapeutick\u00E9 aktivity 131 I na v\u00FDsledky l\u00E9\u010Dby. Pot\u0159ebn\u00E1 data i metodika jsou k dispozici." . "NC4581" . . "0"^^ . "Quantification of the influence of biophysical characteristics on 131I therapy of thyroid cancer"@en . "Kvantitativn\u00ED zhodnocen\u00ED vlivu biofyzik\u00E1ln\u00EDch charakteristik pacient\u016F na v\u00FDsledky terapie karcinom\u016F \u0161t\u00EDtn\u00E9 \u017El\u00E1zy 131 I" . . . . . . . "10"^^ . "10"^^ . . . . "http://www.isvav.cz/projectDetail.do?rowId=NC4581"^^ . . "0"^^ . . . "A proper therapy of thyroid cancer by 131 I destroys tumours but not healthy tissues.The patient\u00B4s biokinetics gives an adequate compromise.Its relliable estimation is our former research result.This project prepares optimal administration of 131 I. Its solution improve treatment,radiation protection and their economy.For this,it evaluates influence of patient\u00B4s biokinetics and administered amount of 131 I on therapy results.Both patient data and necessary evaluation techniques are at disposal."@en . . "1"^^ . "Za nejd\u016Fle\u017Eit\u011Bj\u0161\u00ED p\u0159\u00EDnos pr\u00E1ce je mo\u017Eno pokl\u00E1dat d\u016Fkaz mo\u017Enost\u00ED a praktick\u00E9 aplikace dal\u0161\u00EDho zlep\u0161en\u00ED l\u00E9\u010Dby karcinom\u016F \u0161t\u00EDtn\u00E9 \u017El\u00E1zy pomoc\u00ED 131 I p\u0159i sn\u00ED\u017Een\u00ED radia\u010Dn\u00ED z\u00E1t\u011B\u017Ee pacienta a individualizac\u00ED pod\u00E1van\u00E9 terapeutick\u00E9 aktivity. Tento p\u0159\u00EDstup p\u0159isp\u00EDv\u00E1"@cs .